多尼西尔化指纹光谱和形成机制分析
Lei Wang1,2, Wenxia Wang1,2, Dongjie Wang1,2
1The Center for Terahertz Waves, School of Precision Instrument and Opto-electronics Engineering, Tianjin University, Tianjin 300072, China.
The Review of scientific instruments
|November 15, 2024
概括
特拉赫兹光谱学有效地分析了多尼基化物,这是阿尔茨海默病的关键药物. 这种方法确定了特定的吸收峰值,揭示了对水晶结构和药物开发的分子间力量的洞察力.
科学领域:
- 固态化学 固态化学
- 制药分析 制药分析
- 频谱学是一种光谱学.
背景情况:
- 多尼西尔化是阿尔茨海默病治疗的关键药物.
- 了解药物晶体的特性对于制药发展至关重要.
- 太赫兹 (THz) 光谱学提供了一种非破坏性的材料分析方法.
研究的目的:
- 为了分析多尼佩西尔化晶体的太赫兹吸收光谱.
- 识别特征性峰值并了解分子间相互作用.
- 评估THz光谱在制药分析中的有用性.
主要方法:
- 太赫兹时域光谱学 (THz-TDS) 用于获取指纹光谱.
- 固态密度函数理论 (DFT) 的计算用于模拟和分析振动谱.
- 确定了特征性吸收峰值,并与分子振动相关联.
主要成果:
- 鉴定了多内佩西尔化的五个不同的吸收峰值,分别为1.65,2.44,2.56,3.31和3.75 THz.
- DFT计算有助于将这些峰值分配给特定的分子振动.
- 该研究强调了长距离排序和弱相互作用在晶体结构中的作用.
结论:
- 太赫兹光谱法是一种强大而有效的技术,用于表征药物晶体.
- 这种方法为制药化合物中的分子间力量提供了宝贵的见解.
- THz-TDS可以成为一种有价值的工具,用于质量控制和开发像多尼基化物这样的药物.
相关概念视频
IR Frequency Region: Fingerprint Region
765
IR spectra are divided into two main regions: the diagnostic region and the fingerprint region. The diagnostic region of the spectrum lies above 1500 cm−1. The absorptions resulting from single-bond vibrations of the N–H, C–H, and O–H stretch at higher wavenumbers and appear on the left side of the spectrum. The stretching absorptions of the C≡C and C≡N occur between 2100–2300 cm−1. In contrast, those arising from stretching absorptions of the...
765
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)
1.0K
When proton-coupled carbon-13 spectra are simplified by a broadband proton decoupling technique, structural information about the coupled protons is lost. Distortionless enhancement by polarization transfer (DEPT) is a technique that provides information on the number of hydrogens attached to each carbon in a molecule. While the DEPT experiment utilizes complex pulse sequences, the pulse delay and flip angle are specifically manipulated. The resulting signals have different phases depending on...
1.0K
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165


